Research progress on dendritic cell vaccines in cancer immunotherapy

Dendritic cell (DC) vaccines induce specific immune responses that can selectively eliminate target cells. In recent years, many studies have been conducted to explore DC vaccination in the treatment of hematological malignancies, including acute myeloid leukemia and myelodysplastic syndromes, as we...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jifeng, Sun, Hao, Cao, Weijie, Song, Yongping, Jiang, Zhongxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784280/
https://www.ncbi.nlm.nih.gov/pubmed/35074008
http://dx.doi.org/10.1186/s40164-022-00257-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784280/
https://www.ncbi.nlm.nih.gov/pubmed/35074008
http://dx.doi.org/10.1186/s40164-022-00257-2

Ejemplares similares